May 26, 2015

GNS Healthcare CEO Colin Hill to Address AHIP Institute 2015 General Session

ahip-logo-1CAMBRIDGE, Mass. – May 26, 2015 – Precision medicine pioneer Colin Hill will be a featured speaker at AHIP Institute 2015, offering a real-world view of how precision medicine is converging with population health to enable truly individualized interventions and dramatically improve return on population health investments. Hill is chairman and CEO of GNS Healthcare, a leading provider of value-based analytics solutions for driving personalized interventions that improve population health.

“Precision medicine, powered by machine learning and big data analytics, is bringing a new level of certainty to care management,” says Colin Hill, CEO and co-founder of GNS. “Whether it’s the choice of a therapeutic medication, a conversation with a provider, or a nudge from a health plan to help people get back on track with any number of health goals, it is now possible to know, in advance, the value of interventions to specific individuals and to achieve a positive return on population health investments.”

GNS is widely recognized as one of the first companies to harness the power of big data-driven analytics to solve costly and persistent healthcare challenges. Under Hill’s leadership, GNS has been at the forefront of the precision medicine movement since 2000. The company has delivered big data-driven solutions in premature birth, medication adherence, multiple myeloma, Huntington’s disease, metabolic syndrome, diabetes, asthma, breast and colorectal cancer, multiple sclerosis, rheumatoid arthritis, childhood asthma, and more.

The general session featuring Hill, “Precision Medicine Meets Population Health,” is on Friday, June 5, from 9:15 to 9:45 a.m. Central (CDT) at Music City Center in Nashville. Veteran healthcare journalist Susan Dentzer, senior policy adviser to the Robert Wood Johnson Foundation and an on-air health policy analyst with PBS NewsHour, will interview Hill on stage at the conclusion of his presentation.

GNS will have a presence in the Cambia Grove booth, #1127, during AHIP Institute. The event begins June 3 and concludes June 5.

About GNS Healthcare
GNS Healthcare provides analytic solutions that predict the impact of interventions at the individual level to optimize population health investments. Based on the MAX™ Care Management Architecture and patented REFS™ inference engine, GNS helps health plans, providers, and biopharma companies plan, implement and measure interventions that benefit individuals and drive population-level ROI. These cloud-based solutions are being deployed to improve outcomes associated with medication non-adherence, metabolic syndrome, diabetes, pre-term birth, and specialty care medications. GNS solutions focus on reducing adverse events, slowing disease progression, and improving therapeutic effectiveness through precision selection that reduces wasteful spending and maximizes impact.
GNS Healthcare, Driving Intelligent Interventions

Media Contact
Gina Veazey